Both astrocytomas and oligodendrogliomas may express mutations of the IDH1 or IDH2 genes that result in the abnormal production of 2-hydroxyglutarate; this metabolite can modify DNA methylation of normal neural and glial progenitor cells causing them to produce neoplastic glioma cells.